Literature DB >> 19789204

Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor.

Jacques Pantel1, Marie Legendre, Sylvie Nivot, Séverine Morisset, Marie-Pierre Vie-Luton, Yves le Bouc, Jacques Epelbaum, Serge Amselem.   

Abstract

CONTEXT: Both GH releasing- and orexigenic properties of the gut-to-brain hormone ghrelin are mediated by the GH secretagogue receptor (GHSR). Recently in several patients, a missense mutation (p.A204E) resulting in a complete loss of GHSR constitutive activity has been implicated in short stature with dominant transmission.
OBJECTIVE: The objective of the study was to describe the phenotype associated with partial isolated GH deficiency of a young patient born to unrelated parents and identify the molecular basis of his disease.
RESULTS: The growth delay (-3.0 sd) was associated with recurrent episodes of abdominal pain, vomiting, ketosis, hypoglycemia, and a low body mass index. GHSR sequencing revealed that the patient was compound heterozygous for two new defects: 1) an early occurring transition predicting a premature stop codon (c.6G>A, p.W2X) inherited from his unaffected father, therefore strongly arguing against haploinsufficiency as a disease mechanism, and 2) a missense mutation (c.709A>T, p.R237W) inherited from his healthy mother, involving an evolutionary invariant residue from the third intracellular loop. In vitro experiments showed that the p.R237W mutation would result in a partial loss of constitutive activity of the receptor, whereas both its ability to respond to ghrelin and its cell surface expression are preserved.
CONCLUSION: These data, which describe the first case of recessive partial isolated GH deficiency due to GHSR mutations and emphasize the physiological importance of the GHSR in somatic growth, are discussed in light of the dominantly expressed p.A204E mutation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789204     DOI: 10.1210/jc.2009-1327

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  G protein-coupled receptors: mutations and endocrine diseases.

Authors:  Gilbert Vassart; Sabine Costagliola
Journal:  Nat Rev Endocrinol       Date:  2011-02-08       Impact factor: 43.330

Review 2.  Genetic evaluation of short stature.

Authors:  Andrew Dauber; Ron G Rosenfeld; Joel N Hirschhorn
Journal:  J Clin Endocrinol Metab       Date:  2014-06-10       Impact factor: 5.958

Review 3.  Screening Gene Knockout Mice for Variation in Bone Mass: Analysis by μCT and Histomorphometry.

Authors:  David W Rowe; Douglas J Adams; Seung-Hyun Hong; Caibin Zhang; Dong-Guk Shin; C Renata Rydzik; Li Chen; Zhihua Wu; Gaven Garland; Dana A Godfrey; John P Sundberg; Cheryl Ackert-Bicknell
Journal:  Curr Osteoporos Rep       Date:  2018-04       Impact factor: 5.096

Review 4.  Genetic causes and treatment of isolated growth hormone deficiency-an update.

Authors:  Kyriaki S Alatzoglou; Mehul T Dattani
Journal:  Nat Rev Endocrinol       Date:  2010-10       Impact factor: 43.330

Review 5.  Advances in differential diagnosis and management of growth hormone deficiency in children.

Authors:  Camille Hage; Hoong-Wei Gan; Anastasia Ibba; Giuseppa Patti; Mehul Dattani; Sandro Loche; Mohamad Maghnie; Roberto Salvatori
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

Review 6.  The cellular and molecular bases of leptin and ghrelin resistance in obesity.

Authors:  Huxing Cui; Miguel López; Kamal Rahmouni
Journal:  Nat Rev Endocrinol       Date:  2017-02-24       Impact factor: 43.330

7.  United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood.

Authors:  Charmian A Quigley; Anthony J Zagar; Charlie Chunhua Liu; David M Brown; Carol Huseman; Lynne Levitsky; David R Repaske; Eva Tsalikian; John J Chipman
Journal:  Int J Pediatr Endocrinol       Date:  2013-02-13

Review 8.  Genetics of isolated growth hormone deficiency.

Authors:  Primus E Mullis
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-05-01

9.  GHS-R1a constitutive activity and its physiological relevance.

Authors:  Yves Mear; Alain Enjalbert; Sylvie Thirion
Journal:  Front Neurosci       Date:  2013-05-29       Impact factor: 4.677

10.  CMIP interacts with WT1 and targets it on the proteasome degradation pathway.

Authors:  Shao-Yu Zhang; Qingfeng Fan; Anissa Moktefi; Virginie Ory; Vincent Audard; Andre Pawlak; Mario Ollero; Dil Sahali; Carole Henique
Journal:  Clin Transl Med       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.